Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XLV vs JDOC overlap: 62% of top holdings shared

Bottom line

How much do XLV and JDOC overlap?

62% of their top holdings overlap by weight. 15 securities appear in both funds' top 25, making up 66.8% of XLV's assets and 55.8% of JDOC's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

XLVJDOC
Weight overlap (top 25)62%
Shared holdings15
Weight in shared holdings66.8%55.8%
Total positions6561
Expense ratio0.08%0.65%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings XLV and JDOC have in common

Holding% of XLV% of JDOCOverlap
Eli Lilly & Co16.51%7.76%7.76%
Johnson & Johnson10.64%4.82%4.82%
AbbVie Inc7.74%7.85%7.74%
UnitedHealth Group Inc6.57%5.85%5.85%
Merck & Co Inc5.52%4.82%4.82%
Thermo Fisher Scientific Inc3.24%3.73%3.24%
Abbott Laboratories2.75%3.11%2.75%
Intuitive Surgical Inc2.45%1.93%1.93%
CVS Health Corp2.30%2.83%2.30%
Danaher Corp2.09%2.16%2.09%
Bristol-Myers Squibb Co2.05%3.57%2.05%
Stryker Corp1.89%2.23%1.89%
Regeneron Pharmaceuticals Inc1.08%1.60%1.08%
Cardinal Health Inc0.97%1.51%0.97%
Cencora Inc0.96%2.07%0.96%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XLV

  1. Amgen Inc — 3.40%
  2. Gilead Sciences Inc — 2.73%
  3. Pfizer Inc — 2.39%
  4. Vertex Pharmaceuticals Inc — 2.19%
  5. Medtronic PLC — 1.75%
  6. McKesson Corp — 1.58%
  7. Elevance Health Inc — 1.46%
  8. Cigna Group/The — 1.27%
  9. Boston Scientific Corp — 1.10%
  10. HCA Healthcare Inc — 1.05%

Only in JDOC

  1. AstraZeneca plc — 3.76%
  2. Roche Holding AG — 2.82%
  3. Novo Nordisk A/S — 2.61%
  4. GSK plc — 2.47%
  5. Argenx SE — 2.06%
  6. Edwards Lifesciences Corp. — 1.73%
  7. IQVIA Holdings, Inc. — 1.71%
  8. Teva Pharmaceutical Industries Ltd. — 1.60%
  9. Novartis AG — 1.60%
  10. Biogen, Inc. — 1.56%

Asset mix

Asset typeXLVJDOC
Stocks99.7%99.2%
Cash & short-term funds0.3%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryXLVJDOC
US97.9%75.2%
GB—6.2%
CH—4.4%
DK—4.0%
JP—2.5%
NL—2.4%
IE2.1%0.4%
DE—1.9%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do XLV and JDOC overlap?
About 62% by weight. 15 securities appear in both funds' top 25 holdings; they make up 66.8% of XLV's assets and 55.8% of JDOC's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do XLV and JDOC have in common?
The largest shared holdings are Eli Lilly & Co, AbbVie Inc, UnitedHealth Group Inc, Merck & Co Inc, Johnson & Johnson.
Should I own both XLV and JDOC?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, XLV or JDOC?
XLV is broader, with 65 positions versus 61 for JDOC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.